[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334828-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-334828-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","non-metastatic-primary-neuroendocrine-neoplasms-of-the-breast-a-reference-cancer-centers-experience","Non-metastatic primary neuroendocrine neoplasms of the breast - a reference cancer center’s experience","","Primary neuroendocrine neoplasms of the breast (Br-NENs) are rare, and updated classification systems have increased the difficulty of interpreting published data. It remains uncertain whether neuroendocrine differentiation relates to prognosis and which treatments should be used. A retrospective database of breast cancer patients treated from 2009 to 2022 at the Maria Sklodowska-Curie National Research Institute of Oncology Branch Krakow was analyzed to identify Br-NENs and evaluate clinicopathologic features and outcomes.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/non-metastatic-primary-neuroendocrine-neoplasms-of-the-breast-a-reference-cancer-centers-experience/334828/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/non-metastatic-primary-neuroendocrine-neoplasms-of-the-breast-a-reference-cancer-centers-experience/334828.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about Br-NENs?","Question",{"text":63,"@type":64},"The study examines whether neuroendocrine differentiation affects prognosis and what treatment approaches may be appropriate, noting the challenge caused by updated classification systems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were patients selected and analyzed?",{"text":68,"@type":64},"Patients with breast cancer treated between 2009 and 2022 at the Maria Sklodowska-Curie National Research Institute of Oncology Branch Krakow were searched for Br-NENs, and their medical and pathological data were collected and analyzed.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main results regarding patient characteristics and outcomes?",{"text":72,"@type":64},"The study included 22 female Br-NEN patients without metastases at diagnosis, reporting hormone receptor positivity in most cases, HER-2 negativity, median Ki-67 of 27%, and ongoing survival in patients who developed metastatic disease involving the lungs.",{"name":74,"@type":61,"acceptedAnswer":75},"What treatment recommendations does the paper suggest?",{"text":76,"@type":64},"It suggests radical surgery and postoperative radiotherapy as for non-special-type breast cancer, and recommends considering platinum-based chemotherapy for poorly differentiated Br-NENs with high Ki-67.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},334828,1790112541,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":117,"preview_page_count":4},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","TYPE Original Research PUBLISHED 10 May 2024  \nDOI 10.3389/fendo.2024.1217495  \nOPEN ACCESS  \nEDITED BY  \nHuanwen Wu,  \nPeking Union Medical College Hospital (CAMS), China  \nREVIEWED BY  \nMonica Verrico,  \nSapienza University of Rome, Italy Tomasz Kubiatowski,  \nCenter of Oncology of the Lublin Region St. Jana z Dukli in Lublin, Poland  \nAlessandro Rizzo,  \nNational Cancer Institute Foundation (IRCCS), Italy  \n*CORRESPONDENCE Mirosława Püsküllüo˘glu  \n miroslawa. puskulluoglu@ [onkologia.krakow.pl](onkologia.krakow.pl)  \nRECEIVED 05 May 2023  \nACCEPTED 16 April 2024  \nPUBLISHED 10 May 2024  \nCITATION  \nPüsküllüo˘glu M, Grela-Wojewoda A, Ambicka A, Pacholczak-Madej R, Pietruszka A, Mucha-Małecka A, Rudzin´ska A, Ziobro M, Ry´s J and Mitu´s JW (2024) Non-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center’s experience of a heterogenous entity.  \nFront. Endocrinol. 15:1217495 .  \ndoi: 10.3389/fendo.2024.1217495  \nCOPYRIGHT  \n© 2024 Püsküllüo˘glu, Grela-Wojewoda, Ambicka, Pacholczak-Madej, Pietruszka, Mucha-Małecka, Rudzin´ska, Ziobro, Ry´s and Mitu´s . This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nNon-metastatic primary neuroendocrine neoplasms of the breast: a reference cancer center’s experience of a heterogenous entity  \nMirosława Püsküllüo˘glu 1*, Aleksandra Grela-Wojewoda 1, Aleksandra Ambicka 2, Renata Pacholczak-Madej 1,3, Agnieszka Pietruszka 1, Anna Mucha-Małecka4, Agnieszka Rudzi ´nska 1, Marek Ziobro 1, Janusz Ry´s2 and Jerzy W. Mitu´s3,5  \n1 Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krako´w, Poland, 2 Department of Tumour Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Krako´w, Poland, 3 Department of Anatomy, Jagiellonian University Medical College, Krako´w, Poland, 4 Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Krako´ w Branch, Krako´w, Poland, 5 Department of Surgical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krako´ w, Poland  \nBackground: Primary neuroendocrine neoplasms of the breast (Br-NENs) are rare. The classiﬁcation has been updated in recent years making interpretation of the data published challenging. It is unclear whether neuroendocrine differentiation is associated with poorer prognosis and what treatment approaches should be applied.  \nMethods: The database for breast cancer patients treated between 2009 and 2022 at the Maria Sklodowska-Curie National Research Institute of Oncology Branch Krakow was explored to search for Br-NENs. Patients ’ medical and pathological data were collected and analyzed.  \nResults: We included 22 females with Br-NEN without metastases at the time of diagnosis. The median age was 64 years (range: 28-88), Of the cases, 18 were hormone receptor positive, all were HER-2 negative, the median Ki67 was 27%(10-100%) . The median tumor size at the time of diagnosis was 29 . 5mm (7- 75mm), 9 patients were N-positive. DCIS was present in 5 cases. Only one case was negative for chromogranin and synaptophysin staining, but data were missing for 4 cases. Nine patients received adjuvant chemotherapy, mainly based on anthracyclines and taxanes, while 16 received adjuvant hormonal therapy and 15 received postoperative radiotherapy. Radical surgery was performed in all patients, but two underwent suboptimal tumorectomy. One patient had local recurrence, three experienced metastatic disease, all involving the lungs, but these patients are still alive. The median follow-up was 96 months (8–153) . Two pati","cbCaipm0WovM9fjI","https://ap.wps.com/l/cbCaipm0WovM9fjI","pdf",9820154,12,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What question does the study address about Br-NENs?\",\"answer\":\"The study examines whether neuroendocrine differentiation affects prognosis and what treatment approaches may be appropriate, noting the challenge caused by updated classification systems.\"},{\"question\":\"How were patients selected and analyzed?\",\"answer\":\"Patients with breast cancer treated between 2009 and 2022 at the Maria Sklodowska-Curie National Research Institute of Oncology Branch Krakow were searched for Br-NENs, and their medical and pathological data were collected and analyzed.\"},{\"question\":\"What were the main results regarding patient characteristics and outcomes?\",\"answer\":\"The study included 22 female Br-NEN patients without metastases at diagnosis, reporting hormone receptor positivity in most cases, HER-2 negativity, median Ki-67 of 27%, and ongoing survival in patients who developed metastatic disease involving the lungs.\"},{\"question\":\"What treatment recommendations does the paper suggest?\",\"answer\":\"It suggests radical surgery and postoperative radiotherapy as for non-special-type breast cancer, and recommends considering platinum-based chemotherapy for poorly differentiated Br-NENs with high Ki-67.\"}]","Non-metastatic primary neuroendocrine neoplasms of the breast - a reference cancer center’s experience | PDF",1790008465]